Arnab Mukherjee1, Steven E Rokita1. 1. Department of Chemistry, Johns Hopkins University , Baltimore, Maryland 21218, United States.
Abstract
A single mutation within a flavoprotein is capable of switching the catalytic activity of a dehalogenase into a nitroreductase. This change in function correlates with a destabilization of the one-electron-reduced flavin semiquinone that is differentially expressed in the nitro-FMN reductase superfamily during redox cycling. The diversity of function within such a superfamily therefore has the potential to arise from rapid evolution, and its members should provide a convenient basis for developing new catalysts with an altered specificity of choice.
A single mutation within a flavoprotein is capable of switching the catalytic activity of a dehalogenase into a nitroreductase. This change in function correlates with a destabilization of the one-electron-reduced flavin semiquinone that is differentially expressed in the nitro-FMN reductase superfamily during redox cycling. The diversity of function within such a superfamily therefore has the potential to arise from rapid evolution, and its members should provide a convenient basis for developing new catalysts with an altered specificity of choice.
Enzymes capable of reducing
nitro groups are key to a wide range of applications, including bioremediation,[1] fine chemical production,[2] and drug activation.[3] One class of nitroreductases
(NRs) promotes single-electron transfer and exhibits sensitivity to
oxygen. This latter property has generally limited their utility,
despite success in detecting hard tumors and activating prodrugs in
vivo.[4] An alternative class of NRs are
oxygen-insensitive based on their ability to promote hydride transfer
and suppress single-electron processes. This class provides most opportunities
in industry and medicine and has inspired the search for new NRs by
genomic sequencing.[5] Considerable effort
has also been devoted to engineer existing NRs[6] for optimizing their regiospecificity, catalytic efficiency,
and stability. NRs have additionally been engineered from a nontraditional
source[6b] but not from enzymes that share
a similar architecture yet diverge in catalytic function. The latter
strategy has now generated a new NR by substitution of only a single
amino acid.The majority of oxygen-insensitive NRs belong to
a structural superfamily
of flavoproteins entitled nitro-FMN reductases.[1c] These proteins share an ability to destabilize the one-electron
(1e–)-reduced flavin semiquinone (FMNsq) and consequently inhibit single-electron processes.[7] Not even a trace of the FMNsq (<0.03%)
was detected after careful titration of an NR from its oxidized form
(FMNox) to its two-electron (2e–)-reduced
hydroquinone (FMNhq) (eq ). Recently, another branch of this superfamily
has been identified. This includes enzymes with two quite divergent
activities, and both likely require stabilization of FMNsq.[8] One has been entitled a flavin destructase
(BluB) for its O2-dependent conversion of FMN into 5,6-dimethylbenzimidazole.[9] The second, entitled iodotyrosine deiodinase
(IYD), catalyzes reductive dehalogenation of halotyrosines.[10,11] In contrast to NR, BluB and IYD do not utilize NAD(P)H directly
but rather require a separate reductase to generate their FMNhq in vivo.[9,12] Since the reductase for IYD has
not yet been identified, dithionite has become the reductant of choice
for the majority of studies, including those below.An
empirical correlation emerges for the nitro-FMN reductase superfamily
with regard to catalytic function and the type of hydrogen bonding
available to the N5 position of the bound FMN. NR provides an amide
NH for interacting with the FMN N5, whereas IYD and BluB provide
a side-chain OH from Thr or Ser. Due to the importance of the N5 position
in the redox chemistry of FMN,[13] this dichotomy
had the potential to predict the redox chemistry as well. Thus, IYD
became an interesting candidate for generating an NR by changing a
single hydrogen-bonding partner (eq ). IYD was also appealing since an early survey of
inhibitors suggested that both nitro- and dinitrotyrosine likely
bind tightly to the active site of IYD.[14]IYD was first discovered in humans while the biochemical origins
of thyroid disease were being investigated.[15] This enzyme has since been identified in numerous metazoa and certain
bacteria but not plants, fungi, or protozoa.[11] Native IYD from bacteria lack a membrane anchor common to the mammalian
enzyme, and heterologous expression of the gene from Haliscomenobacter
hydrossis has produced the most robust deiodinase (hhIYD)
to date.[11] This represents a particularly
appealing target for environmental engineering since H. hydrossis can be found in sewage treatment plants.[16] Wild-type (wt) hhIYD has been expressed again as a control for the
studies described below. The rate constants for deiodination of diiodotyrosine
(I2-Tyr) are similar to those determined previously (Table , Figure S2),[11] and I2-Tyr binds wt hhIYD with high affinity, as measured by a standard
assay based on quenching the fluorescence of the active-site FMNox.[17] This same fluorescence assay
has now confirmed that nitrotyrosine(O2N-Tyr) strongly
associates with wt hhIYD, although its KD is 6-fold higher than that of I2-Tyr (Table , Figure S1). If O2N-Tyr adopts the same orientation as I-Tyr
in the active site of IYD, then the nitro group will aligned with
the FMN in analogy to its position in NRs.[18]
Table 1
Catalytic Properties of wt hhIYD and
Its T173A Mutant
I2-Tyr
O2N-Tyr
protein
kcat (min–1)
KM (μM)
kcat/KM (μM–1min–1)
KD (μM)
KD (μM)
wt
hhIYD
14 ± 2
4 ± 1
3 ± 1
2.9 ± 0.1
17 ± 2
T173A hhIYD
5.6 ± 0.7
35 ± 8
0.2 ± 0.04
2.6 ± 0.2
5.3 ± 0.7
The basal
ability of wt hhIYD to promote reduction of a nitro group
was initially surveyed by the propensity of O2N-Tyr to
discharge the reducing equivalents of enzyme-bound FMNhq. This same strategy had already been applied successfully when first
exploring the dechlorinase and debrominase activity of mouseIYD.[17] Stoichiometric addition of dithionite
to wt hhIYD under anaerobic conditions reduced its FMNox to FMNhq, as evident from the dramatic loss of absorbance
at 450 nm (Figure A). Subsequently, the FMNox spectrum was restored almost
completely by addition of 10 μM I2-Tyr. Only a minimal
excess of C–I bonds (20 μM) was required for this oxidation
of the FMNhq-containing wt hhIYD (18 μM). In contrast,
treatment of the reduced FMNhq form of wt hhIYD with O2N-Tyr did not restore the full FMNox spectrum and
instead generated a signal derived primarily from the neutral FMNsq (Figure A, eq ).[19] Thus, only limited reduction of O2N-Tyr was possible before wt hhIYD stalled in a nonproductive
and partially oxidized form. This effect was observed using a substoichiometric
concentration of O2N-Tyr (8 μM), and even then, the
majority of O2N-Tyr remained unchanged after extensive
incubation (see below). Previously, only trace quantities of the FMNsq had been detected with mouse and humanIYD during turnover
of Cl-, Br-, and I-Tyr.[17,20] In contrast, the inert
analogue F-Tyr dramatically stabilized the 1e–-reduced
FMNsq intermediate during redox titration of humanIYD.[8] The bacterial enzyme wt hhIYD is now shown to
act similarly and readily stabilizes its bound FMNsq in
the presence of F-Tyr during redox titration with xanthine and xanthine
oxidase (Figure A).
Figure 1
Oxidation
and reduction of FMN within wt hhIYD and its T173A mutant.
(A) hhIYD (wt, 18 μM) in NaCl (500 mM), 10% glycerol, and MES
(100 mM, pH 6) containing its FMNox was fully reduced to
its FMNhq form (blue line) by stoichiometric addition of
dithionite under anaerobic conditions. The FMNox signal
(green line) was restored after incubation with I2-TYR
(10 μM) for 30 min. Alternative incubation with O2N-Tyr (8 μM) generated a spectrum (red line) consistent with
a mixture of FMNsq and FMNox that remained unchanged
after 30 min. (B) T173A hhIYD (18 μM) in NaCl (500 mM), 10%
glycerol and MES (100 mM, pH 6) was fully reduced to its FMNhq form (blue line) by stoichiometric addition of dithionite under
anaerobic conditions. Subsequent addition of I2-TYR (10
μM) restored the FMNox signal (green line) after
incubation for 30 min. Alternative addition of O2N-Tyr
(8 μM) also restored the FMNox signal (red line).
Figure 2
Redox titration of wt hhIYD and its T173A mutant in the
presence
of the substrate analogue F-Tyr. (A) FMNox of hhIYD was
reduced by the xanthine/xanthine oxidase method[25] under anaerobic conditions in the presence of
F-Tyr (500 μM). Arrows indicate consumption of FMNox (450 nm) and accumulation of FMNsq (550–625 nm).
(B) FMNox of the T173A mutant was reduced equivalently
under anaerobic conditions in the presence of F-Tyr (500 μM).
The arrow indicates the loss of absorbance at 450 nm associated with
FMNox during its reduction to FMNhq.
Oxidation
and reduction of FMN within wt hhIYD and its T173A mutant.
(A) hhIYD (wt, 18 μM) in NaCl (500 mM), 10% glycerol, and MES
(100 mM, pH 6) containing its FMNox was fully reduced to
its FMNhq form (blue line) by stoichiometric addition of
dithionite under anaerobic conditions. The FMNox signal
(green line) was restored after incubation with I2-TYR
(10 μM) for 30 min. Alternative incubation with O2N-Tyr (8 μM) generated a spectrum (red line) consistent with
a mixture of FMNsq and FMNox that remained unchanged
after 30 min. (B) T173A hhIYD (18 μM) in NaCl (500 mM), 10%
glycerol and MES (100 mM, pH 6) was fully reduced to its FMNhq form (blue line) by stoichiometric addition of dithionite under
anaerobic conditions. Subsequent addition of I2-TYR (10
μM) restored the FMNox signal (green line) after
incubation for 30 min. Alternative addition of O2N-Tyr
(8 μM) also restored the FMNox signal (red line).The lack of full transfer of electrons
from FMNhq to
O2N-Tyr implies that, at least for the nitro-FMN reductase
superfamily, reduction of the nitro group predominantly relies
on a hydride pathway. This in turn suggests that IYD’s stabilization
of FMNsq could be preventing its full discharge of electrons
to O2N-Tyr. Consequently, destabilization of FMNsq had the potential to unmask an efficient NR activity of IYD. Such
destabilization is already a noted feature of NRs,[7] and the correlation between catalytic activity and hydrogen
bonding to the flavin N5 made this region an obvious target for manipulation.
For IYD, hydrogen bonding between a Thr side-chain OH and the N5 position
forms only after a halotyrosine binds to the active site and
coincident with stabilization of its FMNsq intermediate
(Figure A).[8] Mutation of the Thr to an Ala (T173A) in hhIYD
eliminates this hydrogen bond. Such mutation did not affect binding
of I2-Tyr (Table ), as anticipated from the lack of direct contact evident
between the substrate and Thr173 in the crystal structure of mouseIYD.[21] However, this residue does contribute
to the catalytic efficiency of dehalogenation since the kcat/KM for the mutant decreases
15-fold relative to that of wt hhIYD (Table ). An analogous Ser-to-Gly mutation in BluB
similarly diminishes its catalytic activity by 30-fold.[9]Redox titration of wt hhIYD and its T173A mutant in the
presence
of the substrate analogue F-Tyr. (A) FMNox of hhIYD was
reduced by the xanthine/xanthine oxidase method[25] under anaerobic conditions in the presence of
F-Tyr (500 μM). Arrows indicate consumption of FMNox (450 nm) and accumulation of FMNsq (550–625 nm).
(B) FMNox of the T173A mutant was reduced equivalently
under anaerobic conditions in the presence of F-Tyr (500 μM).
The arrow indicates the loss of absorbance at 450 nm associated with
FMNox during its reduction to FMNhq.The T173A mutant of hhIYD gained an unexpected
3-fold increase
in its affinity for O2N-Tyr relative to that of wt hhIYD
(Table ). This is
not likely caused by the loss of hydrogen bonding to the N5 of FMN
and instead may reflect a general easing of the steric constraints
within the active site to accommodate the relatively bulky nitro group.
Most importantly, O2N-Tyr (8 μM) fully oxidize the
FMNhq form of the T173A mutant (18 μM) (Figure B). I2-Tyr (10 μM) also oxidized this form of the mutant but yielded
a trace of the FMNsq (<10%) as well. This single mutation
alone is consequently sufficient to limit formation of the FMNsq intermediate and allow full discharge of the reducing equivalents
of FMNhq to the nitro compound. The lack of FMNsq stabilization by the T173A mutant was similarly evident during its
redox titration in the presence of F-Tyr. No FMNsq was
detected in stark contrast to the results with wt hhIYD (Figures ). These data reinforce
the empirical correlation between 1e– vs 2e– transfer processes, dehalogenation vs nitro reduction
and hydrogen bonding to FMN N5.Substoichiometric quantities
of O2N-Tyr were sufficient
to oxidize FMNhq completely in the T173A mutant. This is
rather common for NRs, since the initial 2e– reduction
of nitro to nitroso is rarely detected and nitrosotyrosine in
particular is highly unstable.[5a,22] Most typically, the
nitroso intermediate rapidly consumes an additional 2e– from NR to form the corresponding hydroxylamine derivative.[6] Less common but highly desired is the ability
of NR to promote full reduction of a nitro compound to its amine derivative.[5b]As a complement to the initial spectrophotometric
analysis
used to monitor FMNhqoxidation in hhIYD, consumption of
O2N-Tyr was monitored by reverse-phase HPLC (Figure S3). Reaction of O2N-Tyr with
the FMNhq form of either wt or its T173A mutant hhIYD practically
ceased after 10 min under ambient conditions in the absence of molecular
oxygen (Figure ).
As anticipated from the spectral studies illustrated by Figures and 2, only approximately 35% of the total O2N-Tyr (8 μM)
was consumed by 18 μM of the reduced form of the wt hhIYD, whereas
100% of O2N-Tyr (8 μM) was consumed by 18 μM
of the equivalent T173A mutant. The initial rate of these reactions
promoted by both enzymes was also considerably faster than that by
free FMNhq under equivalent conditions.
Figure 3
Reduction of O2N-Tyr by enzyme-bound and free FMNhq. Consumption of O2N-Tyr (8 μM) by alternative
addition of the reduced form (18 μM) of wt hhIYD (red points
and line), its T173A mutant IYD (black points and line), and free
FMNhq (green points and line) under anaerobic conditions
was monitored over time by reverse-phase HPLC (see Figure S3).
Reduction of O2N-Tyr by enzyme-bound and free FMNhq. Consumption of O2N-Tyr (8 μM) by alternative
addition of the reduced form (18 μM) of wt hhIYD (red points
and line), its T173A mutant IYD (black points and line), and free
FMNhq (green points and line) under anaerobic conditions
was monitored over time by reverse-phase HPLC (see Figure S3).Incubation mixtures equivalent
to those of Figure were likewise treated with dansyl chloride
to ensure retention of the possible tyrosine products on a reverse-phase
column. Only one species was observed after O2N-Tyr reduction
with the T173A mutant, and its elution time corresponded to the conjugate
of l-3-amino-tyrosine(H2N-Tyr) containing two
dansyl groups (Figure A,C). Coupling by two dansyl groups is typical of tyrosine,[23] and the identity of the didansylated derivative
was further confirmed by mass spectrometry (Figure S4). Low yields of the (H2N-Tyr)dansyl2 and (O2N-Tyr)dansyl2 were observed after reaction
with the wt hhIYD (Figure B), consistent with the partial turnover of wt hhIYD as first
revealed by UV–vis spectroscopy (Figure A).
Figure 4
Detection of the O2N-Tyr reduction
product after derivatization
by dansyl chloride. O2N-Tyr (8 μM) was alternatively
treated under anaerobic conditions for 50 min with (A) the reduced
mutant T173A (18 μM) and (B) the reduced wt hhIYD (18 μM).
(C) A standard of H2N-Tyr. (D) A standard of O2N-Tyr. Each sample and standard was ultimately treated with dansyl
chloride (500 μM) before separation on reverse-phase C-18 HPLC
using a gradient of solvent A (25 mM ammonium formate pH 5.7 and 14%
acetonitrile) and B (acetonitrile) according to 0% B for 0–5
min; 0–8% B from 5 to 10 min; 8% B from 10 to 25 min; 8–45%
B from 25 to 55 min; 45–58% B from 55 to 60 min (1 mL/min).
Detection of the O2N-Tyr reduction
product after derivatization
by dansyl chloride. O2N-Tyr (8 μM) was alternatively
treated under anaerobic conditions for 50 min with (A) the reduced
mutant T173A (18 μM) and (B) the reduced wt hhIYD (18 μM).
(C) A standard of H2N-Tyr. (D) A standard of O2N-Tyr. Each sample and standard was ultimately treated with dansyl
chloride (500 μM) before separation on reverse-phase C-18 HPLC
using a gradient of solvent A (25 mM ammonium formate pH 5.7 and 14%
acetonitrile) and B (acetonitrile) according to 0% B for 0–5
min; 0–8% B from 5 to 10 min; 8% B from 10 to 25 min; 8–45%
B from 25 to 55 min; 45–58% B from 55 to 60 min (1 mL/min).Full reduction of O2N-Tyr to H2N-Tyr was
not initially expected by the T173A mutant since NRs from the same
superfamily do not typically provide sufficient reducing potential
for this transformation.[7] The stoichiometry
of O2N-Tyr reduction to H2N-Tyr by FMNhq was also not consistent with contributions from the enzyme alone.
Three equivalents of enzyme-bound FMNhq would have been
consumed if it were solely responsible for reducing O2N-Tyr
to H2N-Tyr. Instead, slightly more than 2 equiv of the
reduced T173A mutant (18 μM) was consumed by O2N-Tyr
(8 μM) reduction, as measured by UV–vis spectroscopy
(Figure B). Subsequent
HPLC analysis confirmed this same stoichiometry (Figure S5). The additional reducing equivalents necessary
to form H2N-Tyr likely derive from the bisulfite that is
generated during dithionite oxidiation.[24] This byproduct (500 μM) does not react with O2N-Tyr
(8 μM) under anaerobic conditions comparable to those used for
enzyme reaction (Figure S6) but does reduce
a model intermediate, phenylhydroxylamine (8 μM),
to aniline under equivalent conditions (Figure S6).Multiple turnovers of reductive dehalogenation can
be measured
for IYD using excess dithionite since the aryl halide bond is stable
to this source of reducing equivalents. In contrast, the nitro group
is reduced spontaneously by dithionite, and thus the NR activity of
IYD was initially measured in the absence of excess dithionite by
single turnover of its FMNhq to FMNox forms.
However, the T173A mutant is capable of multiple turnovers as an NR.
Sequential addition of dithionite and O2N-Tyr for three
cycles demonstrated full reduction and subsequent oxidation of its
FMN (19 μM) and full consumption of three additions of O2N-Tyr (9 μM each) (Figure S7). Continuous turnover of the T173A mutant will also be possible
once its native reductase or an appropriate surrogate is discovered.
Efforts to find this reductase are ongoing and driven in part by its
significance to iodide homeostasis in vertebrates.[10]Only a single mutation of T173A endows
the dehalogenase IYD with
a new ability to catalyze reduction of a nitroaromatic substrate.
This amino acid substitution is sufficient to alter hydrogen bonding
to the N5 position of FMN and switch its ability to promote one- versus
two-electron transfer processes. A correlation between catalytic function
and hydrogen bonding at this position was evident in the nitro-FMN
reductase superfamily but not previously recognized as a primary control
of the catalytic chemistry. The results of this investigation illustrate
how functional diversity within an enzyme superfamily may arise
rapidly during evolution. In addition, the mutant T173A now offers
a new platform to engineer unique NRs for in vivo and in vitro application
as a complement to those efforts currently based on native NRs.
Authors: Michiko E Taga; Nicholas A Larsen; Annaleise R Howard-Jones; Christopher T Walsh; Graham C Walker Journal: Nature Date: 2007-03-22 Impact factor: 49.962
Authors: Seth R Thomas; Patrick M McTamney; Jennifer M Adler; Nicole Laronde-Leblanc; Steven E Rokita Journal: J Biol Chem Date: 2009-05-12 Impact factor: 5.157
Authors: David Jarrom; Mansooreh Jaberipour; Christopher P Guise; Simon Daff; Scott A White; Peter F Searle; Eva I Hyde Journal: Biochemistry Date: 2009-08-18 Impact factor: 3.162
Authors: Jian-Xin Duan; Hailong Jiao; Jacob Kaizerman; Timothy Stanton; James W Evans; Leslie Lan; Gustavo Lorente; Monica Banica; Don Jung; Jinwei Wang; Huaiyu Ma; Xiaoming Li; Zhijian Yang; Robert M Hoffman; W Steve Ammons; Charles P Hart; Mark Matteucci Journal: J Med Chem Date: 2008-02-08 Impact factor: 7.446
Authors: Jessica L Klockow; Kenneth S Hettie; Edward L LaGory; Eui Jung Moon; Amato J Giaccia; Edward E Graves; Frederick T Chin Journal: Sens Actuators B Chem Date: 2019-11-30 Impact factor: 7.460
Authors: Anne-Frances Miller; Jonathan T Park; Kyle L Ferguson; Warintra Pitsawong; Andreas S Bommarius Journal: Molecules Date: 2018-01-24 Impact factor: 4.411